If You Could Only Hold 3 Investments for Life, Consider These Discover 3 must-own investments for lifelong growth. From dividend stocks to a market-beating ETF, these picks offer stability, returns, and long-term wealth.
Plug Power, Capri And Frontline Are Among Top Mid Cap Gainers Last Week (Jan 6-10): Are The Others In Your Portfolio? These mid-cap stocks had impressive gains last week, including Inari Medical, Unifirst Corporation, and Walgreens. Are they in your portfolio?
Stryker To Buy Inari Medical In $5 Billion Deal To Bolster Venous Thromboembolism Position Stryker acquires Inari Medical in a $4.9 billion deal, enhancing its vascular portfolio with innovative VTE treatments and a growing global reach.
Inari Medical Catapults 30% On Rumored Stryker Takeover Inari is best-known for its series of catheter-like devices that remove blood clots.
Inari Medical Stock Gets RS Rating Upgrade On Wednesday, Inari Medical stock received an upgrade to its Relative Strength (RS) Rating, from 65 to 72.
FDA Classifies Recall Of Inari Medical's Large Vessel Clot Removal Catheter Device As Most Serious The FDA labels Inari Medical's ClotTriever catheter recall as the most serious, citing risks like device entrapment and pulmonary emboli, linked to injuries and deaths.
7 Leading MedTech Stocks for Next-Gen Health Solutions With healthcare innovations promising to deliver groundbreaking solutions, these MedTech stocks should be on your radar.
NARI Stock Earnings: Inari Medical Misses EPS, Beats Revenue for Q2 2024 NARI stock results show that Inari Medical missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
NARI Stock Earnings: Inari Medical Misses EPS, Beats Revenue for Q1 2024 NARI stock results show that Inari Medical missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
